Intermede Investment Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.9M Sell
818,840
-39,673
-5% -$2.64M 3.15% 11
2026
Q1
$53.9M Sell
858,513
-50,794
-6% -$3.54M 2.5% 20
2025
Q4
$60.4M Buy
+909,307
New +$58.8M 2.48% 20

Other funds holding DXCM

Intermede Investment Partners's DXCM Position: Q2 2026 in Review

Intermede Investment Partners reduced its DexCom (DXCM) stake by 4.6% in Q2 2026, selling an estimated $2.64M and leaving 818,840 shares worth $74.9M. The position accounts for 3.15% of the portfolio, ranked #11.

Intermede Investment Partners first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Intermede Investment Partners held 818,840 shares of DexCom worth $74.9M as of Q2 2026.
  • Intermede Investment Partners sold 39,673 DexCom shares in Q2 2026, an estimated $2.64M.
  • DexCom made up 3.15% of Intermede Investment Partners's portfolio in Q2 2026, its #11 holding.
  • Intermede Investment Partners first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Intermede Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.